Skip to main content
The words approved in red capitalized letters

Alembic receives FDA OK for generic Toradol

Ketorolac tromethamine is indicated for the short-term management of moderately severe acute pain in adult patients.
Levy

Alembic has received the Food and Drug Administration’s nod for ketorolac tromethamine injection, 15 mg/ml, 30 mg/ml, and 30 mg/ml single-dose vials.

The drug is the generic of Toradol, which is indicated for the short-term management of moderately severe acute pain in adult patients.

[Read more: Alembic intros generic Perforomist]

Ketorolac tromethamine injection had a market value of roughly $59 million for the 12 months ending June 2022, according to IQVIA.

X
This ad will auto-close in 10 seconds